香鳞毛蕨治疗银屑病的药效物质基础研究的开题报告.docx
上传人:王子****青蛙 上传时间:2024-09-15 格式:DOCX 页数:2 大小:11KB 金币:10 举报 版权申诉
预览加载中,请您耐心等待几秒...

香鳞毛蕨治疗银屑病的药效物质基础研究的开题报告.docx

香鳞毛蕨治疗银屑病的药效物质基础研究的开题报告.docx

预览

在线预览结束,喜欢就下载吧,查找使用更方便

10 金币

下载此文档

如果您无法下载资料,请参考说明:

1、部分资料下载需要金币,请确保您的账户上有足够的金币

2、已购买过的文档,再次下载不重复扣费

3、资料包下载后请先用软件解压,在使用对应软件打开

香鳞毛蕨治疗银屑病的药效物质基础研究的开题报告Title:StudyontheTherapeuticEfficacyandPharmacologicalBasisofXianglinmaojueintheTreatmentofPsoriasisIntroduction:Psoriasisisachronicinflammatoryskindiseasethataffectsmillionsofindividualsworldwide.Despitetheavailabilityofvarioustreatmentoptions,suchastopicalagents,systemicmedications,andbiologics,thetreatmentofpsoriasisremainschallengingduetoitscomplexpathophysiology,geneticpredisposition,andvariableclinicalpresentation.Therefore,thereisaneedfornewsafeandeffectivetreatmentsforpsoriasis.TraditionalChinesemedicine(TCM)haslongbeenusedtotreatvariousskindiseases,includingpsoriasis.Xianglinmaojue(XL)isatypeofTCMderivedfromtherhizomeofDryopterisfragrans,whichhasbeenshowntohavepotentialtherapeuticeffectsonpsoriasis.Hypothesis:XLexertsitstherapeuticeffectsonpsoriasisbymodulatingimmuneresponsesandregulatingkeratinocyteproliferationanddifferentiationthroughitsactiveconstituents.Objectives:1.ToinvestigatethetherapeuticefficacyofXLonpsoriasisinananimalmodel.2.ToidentifytheactiveconstituentsofXLusinghigh-performanceliquidchromatography(HPLC)andgaschromatography-massspectrometry(GC-MS).3.Toevaluatetheimmunomodulatoryandanti-proliferativeeffectsofXLanditsactiveconstituentsonpsoriasis.Methods:1.Animalmodel:Psoriasis-likelesionswillbeinducedinmicebytopicalapplicationofimiquimod(IMQ)creamtotheshavedbackskin.Themicewillberandomlyassignedtothreegroups:(1)XLtreatmentgroup,(2)IMQ-alonegroup,and(3)vehiclecontrolgroup.TheXLtreatmentgroupwillreceivedailyoraladministrationofXLextractatadoseof500mg/kgbodyweight.TheIMQ-alonegroupwillreceivetopicalapplicationofIMQcreamonly.Thevehiclecontrolgroupwillreceivetopicalapplicationofvehiclecreamonly.Thetreatmentdurationwillbe7days,andtheseverityofskinlesionswillbeassessedusingthePsoriasisAreaandSeverityIndex(PASI)andhistopathologicalanalysis.2.Identificationofactiveconstituents:XLextractwillbeanalyzedusingHPLCandGC-MStoidentifythechemicalconstituents.Theidentifiedcompoundswillbefurthertestedfortheirimmunomodulatoryandan